ShangPharma Technology Group
Investment Details
Investor Type
Private Equity
Asset Class Focus
Private Equity, Venture Capital
Stage Focus
Early Stage, Growth, Late Stage, Pre-IPO, Buyout
Geographical Focus
United States, United Kingdom, Canada, Germany, Japan, Australia, China, India, Brazil, France, Italy, Switzerland, Spain, Mexico, South Korea, Netherlands, South Africa, Russia, Sweden, Belgium
Industries Focus
- Financial Services
- Technology
- Healthcare
- Energy
- Consumer Goods
- Real Estate
- Materials
- Telecommunications
- Media
- Retail
- Logistics
- Transportation
- Hospitality
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Biotechnology
- Chemicals
- Consumer Health
- Environmental Services
- Agricultural Chemicals
Investment Size:
5,000,000 to 50,000,000 USD
Investor Details Founded: 2002
ShangPharma Technology Group is a prominent private equity firm based in China, focusing on investments in the pharmaceutical and biotechnology industries. The firm is dedicated to advancing healthcare by supporting companies that develop innovative medical solutions. Through strategic investments, ShangPharma aims to enhance the global competitiveness of its portfolio companies and contribute to the advancement of medical science.
The firm's investment strategy encompasses a broad spectrum of stages, including early-stage ventures, growth-phase companies, late-stage enterprises, pre-IPO firms, and buyouts. This diversified approach allows ShangPharma to tailor its support to the unique needs of each portfolio company, fostering innovation and growth across various segments of the healthcare industry.
ShangPharma's extensive geographical focus spans multiple countries, including China, the United States, the United Kingdom, Germany, France, Japan, South Korea, India, Brazil, Canada, Australia, Switzerland, the Netherlands, Sweden, Belgium, Italy, Spain, Russia, Mexico, and South Africa. This global reach enables the firm to identify and invest in promising healthcare companies worldwide, leveraging its international network to drive success and innovation in the healthcare sector.
Requirements
- Strong management team
- Innovative product pipeline
- Scalable business model
- Clear regulatory pathway
- Potential for significant market impact
- Alignment with ShangPharma's strategic focus areas
Contact
[Official Website Hidden]
[HQ Location Hidden]
Portfolio Companies
- ChemPartner
- China Gateway Biologics
- China Gateway Pharmaceutical Development
- China Gateway Pharma Products
- ShangPharma Innovation
- ShangPharma Investment Group Limited
- ShangPharma Technology Group (HK) Limited
- PharmaExplorer Limited
- Shanghai ChemPartner Co. Ltd.
- Shanghai ChemExplorer Company Ltd.
- China Gateway Pharmaceutical (Shanghai) Ltd.
- China Gateway Pharma Products (Chengdu) Ltd.
- Shanghai ChemPartner Pharmaceutical Development Co. Ltd.
- Shanghai ChemPartner Biologics Co. Ltd.
- Shanghai ChemPartner Discovery Chemistry Co. Ltd.
- Shanghai ChemPartner Discovery Biology Co. Ltd.
- Shanghai ChemPartner Preclinical Development Co. Ltd.
Claim this Investor
Are you an official representative of ShangPharma Technology Group?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim